CVE-2025-22225 VMware CVE debrief

Who should care

VMware ESXi administrators, virtualization platform owners, cloud operations teams, and incident response/security teams responsible for exposed hypervisors or ESXi-managed infrastructure.

Technical summary

The supplied corpus identifies the issue as an arbitrary write vulnerability in VMware ESXi. CISA’s KEV metadata indicates active exploitation and notes known ransomware campaign use. No CVSS score or deeper vendor technical breakdown is included in the supplied source set, so the safest interpretation is that this is an actively exploited ESXi flaw requiring urgent attention based on KEV status rather than score alone.

Defensive priority

Immediate. This is a CISA KEV-listed ESXi vulnerability with known ransomware campaign use and a remediation due date of 2025-03-25.

Recommended defensive actions

• Check whether any VMware ESXi instances in your environment are affected by CVE-2025-22225.
• Apply vendor mitigations from the official VMware/Broadcom security advisory as soon as possible.
• Prioritize remediation before the CISA KEV due date of 2025-03-25.
• If mitigations are not available, follow CISA BOD 22-01 guidance for cloud services or discontinue use of the product as appropriate.
• Validate exposure across on-premises and cloud-managed virtualization environments.
• Monitor for signs of compromise and review incident response readiness for ESXi hosts.

Evidence notes

This debrief is based on the supplied CISA KEV metadata and official resource links only. The corpus confirms: vendor VMware, product ESXi, vulnerability name "VMware ESXi Arbitrary Write Vulnerability," KEV addition date 2025-03-04, due date 2025-03-25, and known ransomware campaign use. No CVSS score or full vendor advisory text was provided in the source corpus, so technical impact details beyond the arbitrary-write designation are not asserted here.

Official resources